faricimab ophthalmic
Faricimab (Vabysmo) is Formulary, Restricted to use by Devers, for adult patients with exudative age-related macular degeneration or macular edema due to diabetes mellitus who have failed bevacizumab (Avastin).
Faricimab (Vabysmo) is Formulary, Restricted to use by Devers, for adult patients with exudative age-related macular degeneration or macular edema due to diabetes mellitus who have failed bevacizumab (Avastin).